Gabapentin Capsule
Product Images NDC 80425-0033

11 FDA label images from Advanced Rx Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of gabapentin, showing its molecular framework with a cyclohexane ring, an amino group (CH2NH2), and a carboxyl group (CH2CO2H).*
FDA Label Image

Fig. 1 (Fig 1)

Fig. 1 (Fig 1)
A line graph showing mean pain scores over 8 weeks comparing Gabapentin 3600 mg/day and placebo. The x-axis represents weeks from baseline to week 8, and the y-axis represents mean pain scores from 0 to 10. Two periods are noted: a 4-week dose titration and a 4-week fixed dose. Gabapentin shows a marked decline in mean pain scores over time, while placebo remains relatively stable.*
FDA Label Image

Fig. 2 (Fig 2)

Fig. 2 (Fig 2)
Line graph showing mean pain scores over seven weeks comparing placebo and two Gabapentin dosages (1800 mg/day and 2400 mg/day). The x-axis represents time in weeks, including a 3-week dose titration and a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Both Gabapentin groups demonstrate a greater reduction in pain scores compared to placebo.*
FDA Label Image

Fig. 3 (Fig 3)

Fig. 3 (Fig 3)
A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares response rates between placebo (PBO) and Gabapentin (GBP) at different dosages across two studies. Study 1 shows 12% response for placebo versus 29% for GBP 3600 mg. Study 2 shows 14% for placebo versus 32% for GBP 1800 mg and 34% for GBP 2400 mg. Statistical significance is indicated with p-values less than 0.01 and 0.001.*
FDA Label Image

Fig 4 (Fig 4)

Fig 4 (Fig 4)
A scatter plot comparing three studies (a, b, and c) on the difference (%) versus daily dose (mg) for Gabapentin. The horizontal axis represents the daily dose ranging from 600 mg to 1800 mg, and the vertical axis shows the difference percentage from 2% to 22%. Data points are marked for each study at 600, 900, 1200, and 1800 mg doses.*
FDA Label Image

Gabapentin 300mg #30 (Gabapentin 300mg 80425 0033 01)

Gabapentin 300mg #30 (Gabapentin 300mg 80425 0033 01)
Gabapentin 300 mg capsule label from Advanced Rx of Tennessee, LLC with quantity of 30 capsules. Label displays product NDC 80425-0033-01, lot number placeholder, and expiration date 12/31/2027. It includes storage instructions between 20° and 25°C, barcode, and comparison to Neurontin. The label is predominantly green with blue and white accents.*
FDA Label Image

Gabapentin 300mg #60 (Gabapentin 300mg 80425 0033 02)

Gabapentin 300mg #60 (Gabapentin 300mg 80425 0033 02)
Label for Gabapentin 300 mg capsule, package of 60, by Advanced Rx of Tennessee, LLC. The label includes NDC 80425-0033, expiration date 12/31/2027, and storage instructions between 20° and 25°C (68° and 77°F). The label states Rx Only and compares the product to Neurontin.*
FDA Label Image

Gabapentin 300mg #90 (Gabapentin 300mg 80425 0033 03)

Gabapentin 300mg #90 (Gabapentin 300mg 80425 0033 03)
Gabapentin 300 mg capsule label by Advanced Rx of Tennessee, LLC. The label includes product name, strength, dosage form as capsule, NDC number 80425-0033, lot number placeholder, and expiration date 12/31/2027. It references comparison to Neurontin and provides storage instructions between 20° and 25°C. The label also features barcodes, QR codes, and a note for prescription use only.*
FDA Label Image

Gabapentin 300mg #40 (Gabapentin 300mg 80425 0033 04)

Gabapentin 300mg #40 (Gabapentin 300mg 80425 0033 04)
The label for Gabapentin 300 mg capsules, package count 40, manufactured by Advanced Rx of Tennessee, LLC. It includes NDC 80425-0033-04, comparison to Neurontin, lot and expiration details, storage instructions between 20° and 25°C, and barcodes for scanning. The label emphasizes Rx only status and includes source NDC information for ASCEND LABORATO.*
FDA Label Image

Gabapentin 300mg # 120 (Gabapentin 300mg 80425 0033 05)

Gabapentin 300mg # 120 (Gabapentin 300mg 80425 0033 05)
Label for Gabapentin 300 mg capsule, package of 120 capsules, labeled by Advanced Rx of Tennessee, LLC. The label includes NDC 80425-0033-05, expiration date 12/31/2027, and storage instructions to keep between 20° and 25°C (68° and 77°F). It also references comparison to Neurontin and includes lot and source NDC information, barcode, and QR codes.*
FDA Label Image

Gabapentin 300mg # 9 (Gabapentin 300mg 80425 0033 06)

Gabapentin 300mg # 9 (Gabapentin 300mg 80425 0033 06)
Label for Gabapentin 300 mg capsule, packaged by Advanced Rx of Tennessee, LLC, Nashville, TN. The label includes storage instructions, NDC 80425-0033-06, and expiration date 12/31/2027. It references comparison to Neurontin and indicates prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.